Cargando…
GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
Previous studies have shown that metabolomics can be a useful tool to better understand the mechanisms of carcinogenesis; however, alterations in biochemical pathways that lead to bladder cancer (BC) development have hitherto not been fully investigated. In this study, gas chromatography-mass spectr...
Autores principales: | Rodrigues, Daniela, Pinto, Joana, Araújo, Ana Margarida, Jerónimo, Carmen, Henrique, Rui, Bastos, Maria de Lourdes, Guedes de Pinho, Paula, Carvalho, Márcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359170/ https://www.ncbi.nlm.nih.gov/pubmed/30669322 http://dx.doi.org/10.3390/metabo9010018 |
Ejemplares similares
-
Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
por: Lima, Ana Rita, et al.
Publicado: (2018) -
GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
por: Lima, Ana Rita, et al.
Publicado: (2018) -
GC‐MS metabolomics‐based approach for the identification of a potential VOC‐biomarker panel in the urine of renal cell carcinoma patients
por: Monteiro, Márcia, et al.
Publicado: (2017) -
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021) -
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma
por: Monteiro, Márcia S., et al.
Publicado: (2016)